Stock Analysis

Nohmi Bosai Ltd. (TSE:6744) Released Earnings Last Week And Analysts Lifted Their Price Target To JP¥3,800

TSE:6744
Source: Shutterstock

Nohmi Bosai Ltd. (TSE:6744) last week reported its latest third-quarter results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. It was a credible result overall, with revenues of JP¥34b and statutory earnings per share of JP¥142 both in line with analyst estimates, showing that Nohmi Bosai is executing in line with expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

See our latest analysis for Nohmi Bosai

earnings-and-revenue-growth
TSE:6744 Earnings and Revenue Growth February 13th 2025

Taking into account the latest results, the current consensus from Nohmi Bosai's three analysts is for revenues of JP¥136.1b in 2026. This would reflect a modest 6.2% increase on its revenue over the past 12 months. Statutory per-share earnings are expected to be JP¥195, roughly flat on the last 12 months. Before this earnings report, the analysts had been forecasting revenues of JP¥133.4b and earnings per share (EPS) of JP¥193 in 2026. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

With the analysts reconfirming their revenue and earnings forecasts, it's surprising to see that the price target rose 19% to JP¥3,800. It looks as though they previously had some doubts over whether the business would live up to their expectations.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Nohmi Bosai's past performance and to peers in the same industry. It's clear from the latest estimates that Nohmi Bosai's rate of growth is expected to accelerate meaningfully, with the forecast 4.9% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 1.0% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to see revenue growth of 7.2% annually. It seems obvious that, while the future growth outlook is brighter than the recent past, Nohmi Bosai is expected to grow slower than the wider industry.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Nohmi Bosai's revenue is expected to perform worse than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

With that in mind, we wouldn't be too quick to come to a conclusion on Nohmi Bosai. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Nohmi Bosai analysts - going out to 2027, and you can see them free on our platform here.

You can also see our analysis of Nohmi Bosai's Board and CEO remuneration and experience, and whether company insiders have been buying stock.

Valuation is complex, but we're here to simplify it.

Discover if Nohmi Bosai might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:6744

Nohmi Bosai

Engages in the development, marketing, installation, and maintenance of various fire protection systems in Japan, China, rest of Asia, and the United States.

Flawless balance sheet established dividend payer.

Community Narratives

AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Fair Value SEK 2.55k|36.403% undervalued
Unike
Unike
Community Contributor
Leading the Charge in SME SaaS Innovation
Fair Value SEK 100.02|25.014999999999997% undervalued
Investingwilly
Investingwilly
Community Contributor
Brookfield Corporation is a solid BUY for a long-term portfolio
Fair Value CA$82.23|1.7389999999999999% overvalued
Jonataninho
Jonataninho
Community Contributor